National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Healthcare Cost and Utilization Project (HCUP) (2)
- (-) Healthcare Costs (5)
- Healthcare Utilization (1)
- Health Information Technology (HIT) (1)
- (-) Hospitalization (5)
- Injuries and Wounds (1)
- Maternal Care (1)
- Medication (1)
- Medication: Safety (1)
- Newborns/Infants (1)
- Opioids (1)
- Provider: Pharmacist (1)
- Skin Conditions (1)
- Substance Abuse (1)
- Telehealth (1)
- Transplantation (1)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 5 of 5 Research Studies DisplayedTaber DJ, Fleming JN, Su Z
Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients.
This paper examined hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. This study was an economic analysis of a 12-month, parallel arm, randomized controlled trial in adult kidney recipients 6 to 36 months posttransplant (NCT03247322). All participants received usual posttransplant care, while the intervention arm received supplemental clinical pharmacist-led medication therapy monitoring and management, via a smartphone-enabled mHealth app, integrated with risk-based televisits.
AHRQ-funded; HS023754.
Citation: Taber DJ, Fleming JN, Su Z .
Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients.
Am J Transplant 2021 Oct;21(10):3428-35. doi: 10.1111/ajt.16737..
Keywords: Healthcare Costs, Provider: Pharmacist, Telehealth, Health Information Technology (HIT), Transplantation, Hospitalization, Medication: Safety, Medication
Chua KP, Fendrick AM, Conti RM
Prevalence and magnitude of potential surprise bills for childbirth.
This research letter describes a cross-sectional study that examined surprise bills that are received for childbirths and newborn hospitalizations, and whether new legislation to protect families from surprise bills would have a benefit. The authors analyzed 2019 data from Optum’s deidentified Clinformatics Data Mart and identified families with an in-network delivery in 2019 that could be linked to 1 or more in-network newborn hospitalization that was covered by the same family plan. The analysis included 95,384 families, and of those 17,949 (18.8%) had 1 or more potential surprise bill for the delivery, newborn hospitalization(s), or both. The median total liability for potential surprise bills was $744 for 6417 families, with total liability exceeding $2000. Among 32,203, and 63,181 deliveries with and without 1 or more cesarean delivery, 6594 (20.5%) and 5597 (8.9%) had 1 or more potential surprise bill, with a median liability of $1825 respectively. For 5970 and 90,991 newborn hospitalizations with or without 1 or more neonatal intensive care claim, 15.5% and 8.9% had 1 or more potential surprise bill, with a median liability of $1282 and $262 respectively. While this study was limited by lack of information whether these families actually received surprise bills, the findings suggest that federal protections against surprise bills could benefit many families.
AHRQ-funded; HS025465.
Citation: Chua KP, Fendrick AM, Conti RM .
Prevalence and magnitude of potential surprise bills for childbirth.
JAMA Health Forum 2021 Jul; 2(7):e211460. doi: 10.1001/jamahealthforum.2021.1460..
Keywords: Healthcare Costs, Maternal Care, Newborns/Infants, Hospitalization
Narla S, Silverberg JI
The inpatient burden and comorbidities of pyoderma gangrenosum in adults in the United States.
The objective of this study was to determine the prevalence, predictors, outcomes, and costs of hospitalization for pyoderma gangrenosum (PG) in United States adults. Data from the 2002-2012 National Inpatient Sample were analyzed. Findings showed that PG admissions were more likely at teaching and medium or large hospitals. The majority of inpatients with PG were classified with minor or moderate likelihood of dying, but moderate and major loss of function. PG was associated with numerous other health disorders. This study demonstrated a substantial and increasing inpatient burden of PG in the United States, with considerable disability and mortality risk, multiple comorbid health disorders, and costs.
AHRQ-funded; HS023011.
Citation: Narla S, Silverberg JI .
The inpatient burden and comorbidities of pyoderma gangrenosum in adults in the United States.
Arch Dermatol Res 2021 May;313(4):245-53. doi: 10.1007/s00403-020-02098-7..
Keywords: Healthcare Cost and Utilization Project (HCUP), Skin Conditions, Injuries and Wounds, Hospitalization, Healthcare Costs
Kaltenborn Z, Paul K, Kirsch JD
Super fragmented: a nationally representative cross-sectional study exploring the fragmentation of inpatient care among super-utilizers.
Researchers sought to determine the prevalence of super-utilizers who receive fragmented care across different hospitals and to describe associated risks, costs, and health outcomes. Using HCUP data, they found that inpatient care fragmentation was common among super-utilizers and disproportionately affected vulnerable populations. It was associated with high yearly costs and a decreased probability of correctly identifying super-utilizers.
AHRQ-funded; HS026732.
Citation: Kaltenborn Z, Paul K, Kirsch JD .
Super fragmented: a nationally representative cross-sectional study exploring the fragmentation of inpatient care among super-utilizers.
BMC Health Serv Res 2021 Apr 14;21(1):338. doi: 10.1186/s12913-021-06323-5..
Keywords: Healthcare Cost and Utilization Project (HCUP), Healthcare Costs, Hospitalization
Rapoport AB, Fine DR, Manne-Goehler JM
High inpatient health care utilization and charges associated with injection drug use-related infections: a cohort study, 2012-2015.
This study described the characteristics of patients hospitalized with injection drug use-related infection over a multiyear period in a region highly impacted by the opioid epidemic. Findings revealed a longer average length of stay with subsequent higher cost, a higher percentage of 30-day readmissions, disproportionate public payer mix representation, and higher rates of discharge to alternate facilities for ongoing care as compared with the total inpatient cohort.
AHRQ-funded; HS026215.
Citation: Rapoport AB, Fine DR, Manne-Goehler JM .
High inpatient health care utilization and charges associated with injection drug use-related infections: a cohort study, 2012-2015.
Open Forum Infect Dis 2021 Mar;8(3):ofab009. doi: 10.1093/ofid/ofab009..
Keywords: Opioids, Substance Abuse, Hospitalization, Healthcare Costs, Healthcare Utilization